fda compounding semaglutide enforcement october 2025 news 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Out of Shortage, Into Controversy:

Starting Dose Begin with 0.25 mg daily , especially for first-time users Titrate up to 0.51 mg per day based on tolerance and results Its critical not to exceed recommended doses, as overuse increases the risk of side effects , including hyperpigmentation and nausea

Months 3-6 Many individuals experience some of their most noticeable results during this period

You might experience changes in vision, irregular heartbeat, fever, swelling on the site of injection, or allergic reaction symptoms

A shortage of a commercially available drug is one of the criteria that allows compounded production, as per US Food and Drug Administration (FDA) regulation